Agios Pharmaceuticals Overview
Agios Pharmaceuticals Target Price
Analysts' 12-month price predictions for AGIO.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.58
Average Target Price
$46.67
24.2% upside
24.2% upside3 analysts in the last 4 months
High: $54 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-15 | H.C. WainwrightEmily Bodnar | $54 | 43.7% upside |  |
| 2026-04-30 | Truist Financial | $36 |  4.2% downside | |
| 2026-04-20 | H.C. WainwrightEmily Bodnar | $50 | 33% upside | |
| 2026-02-12 | Truist FinancialGreg Renza | $39 | 3.8% upside | |
| 2025-12-26 | Leerink Partners | $40 | 6.4% upside | |
| 2025-12-24 | H.C. Wainwright | $62 | 65% upside | |
| 2025-12-24 | Truist FinancialGregory Renza | $38 | 1.1% upside | |
| 2025-11-24 | Truist Financial | $32 | 14.8% downside | |
| 2025-11-20 | Goldman Sachs | $25 | 33.5% downside | |
| 2025-11-20 | Leerink Partners | $34 | 9.5% downside | |
| 2025-10-20 | H.C. WainwrightEmily Bodnar | $56 | 49% upside | |
| 2025-05-02 | ScotiabankGreg Harrison | $71 | 88.9% upside | |
| 2024-10-31 | Raymond JamesDanielle Brill | $51 | 35.7% upside | |
| 2024-09-27 | Leerink PartnersAndrew Berens | $56 | 49% upside | |
| 2024-09-10 | Raymond JamesChris Raymond | $56 | 49% upside | |
| 2024-06-17 | Raymond JamesChris Raymond | $55 | 46.4% upside | |
| 2024-06-03 | RBC CapitalGregory Renza | $53 | 41% upside | |
| 2024-05-28 | Raymond JamesChris Raymond | $45 | 19.7% upside | |
| 2023-02-03 | Piper Sandler | $41 | 9.1% upside | |
| 2022-12-01 | J.P. Morgan | $33 | 12.2% downside | |
| 2022-11-17 | Goldman Sachs | $32 | 14.8% downside | |
| 2021-04-30 | BarclaysPeter Lawson | $70 | 86.3% upside | |